# Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area

> **NCT00528294** · PHASE1 · TERMINATED · sponsor: **University Hospital, Ghent** · enrollment: 12 (estimated)

## Conditions studied

- Head and Neck Tumors

## Interventions

- **RADIATION:** GRID radiotherapy

## Key facts

- **NCT ID:** NCT00528294
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 12 (ESTIMATED)
- **Why stopped:** Study status unknown Investigator retired and no longer working in the institution.
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528294, "Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00528294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*